First patient treated in the second dose group in Annexin’s RVO study
Annexin Pharmaceuticals announces that all patients in the first dose group with the lowest dose have now completed treatment in…
Tag: medical research
Avidity Biosciences Announces New Positive AOC 1001 Data Demonstrating Improvement in Multiple Additional Functional Endpoints and Favorable Long-term Safety and Tolerability in People with Myotonic Dystrophy Type 1
Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates…
PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, “Astellas”) and Seagen Inc. (Nasdaq: SGEN) today announced positive topline results…
Lipocine to Present at the Cantor Fitzgerald Global Healthcare Conference
Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders, today announced that Dr. Mahesh…
New drug class prevents key ageing mechanism in organ transplants
A novel study has shown that Senolytics, a new class of drugs, have the potential to prevent the transfer of…
National Jewish Health Appoints Evan Zucker as Chair of Board of Directors
Evan Zucker has been named Chair of the National Jewish Health Board of Directors. He succeeds Steven D. Kris, who…
Chemotherapy before surgery: Cancer Research UK-funded trial reveals new way to reduce colon cancer recurrence risk
A Cancer Research UK-funded clinical trial has discovered a new way of reducing the risk of colon cancer recurrence. The…